The Frances Crick Institute in London has developed a type of personalised vaccine which can cause moles to ‘self-destruct’. It’s thought to help patients at a heightened risk of cancer. The Frances Crick Institute in London has developed a type of personalised vaccine which can cause moles to ‘self-destruct’. It’s thought to help patients at a heightened risk of cancer.